Australia Markets open in 3 hrs 47 mins

Wellfully Limited (WFL.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0370-0.0030 (-7.50%)
At close: 03:54PM AEST

Wellfully Limited

284 Oxford Street
Ground Floor
Leederville, WA 6007
61 8 9443 3011

IndustryDiagnostics & Research
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Paul PerosExec. Chairman & CEO903.46kN/AN/A
Mr. Jeffrey David EdwardsFounder, MD, Technical Director & Exec. Director235.05kN/AN/A
Mr. Sergej DolezilChief Financial OfficerN/AN/AN/A
Dr. Matthew McIldowieChief Scientific OfficerN/AN/AN/A
Mr. Henko Vos C.A.Company Sec.N/AN/AN/A
Dr. Michael RobertsScientific AdviserN/AN/AN/A
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.


Wellfully Limited, together with its subsidiaries, develops dermaportation and enhanced transdermal polymer technologies for use in the pharmaceutical, cosmetic and skincare, and consumer healthcare sectors in Singapore and Europe. It operates in two segments, Dermaportation Drug Delivery Technology and Devices. It develops magnetic micro-array and powerless drug delivery technologies; and designs and develops drug patches, applicators, and brushes products. The company was formerly known as OBJ Limited and changed its name to Wellfully Limited in September 2020. Wellfully Limited was incorporated in 1992 and is based in Leederville, Australia.

Corporate governance

Wellfully Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.